Skip to content

Nasdaq · CIK 0001626878

XBIT XBiotech Inc.

Insider trading from SEC Form 4. Last filing Nov 12, 2025.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
4
with a Form 4 at this company

Signals

Open-market buys and sells at XBiotech Inc., scored.

No scored open-market trades yet. Grants, exercises and other rows are below.

Transactions

The last 4 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2025Thomas Martin Kuendig
director
AGrant or award
Director Stock Optionderivative
+79,115$0.00$079,115Nov 12, 2025
Oct 1, 2025Craig Evan Rademaker
director
AGrant or award
Director Stock Optionderivative
+92,104$0.00$092,104Nov 12, 2025
Oct 1, 2025David Spencer Soffer
director
AGrant or award
Director Stock Optionderivative
+51,000$0.00$051,000Nov 12, 2025
Oct 1, 2025Tevi David Troy
director
AGrant or award
Director Stock Optionderivative
+56,000$0.00$056,000Nov 12, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

XBIT insider trading: XBiotech Inc. | InsiderTell